Study of BPL's FX in FX deficient patients requiring surgery Version 1

• Research type

  Research Study

• Full title

  A Phase III Open, Multicentre Study to Investigate the Safety and Efficacy of BPL’s High Purity FACTOR X in the Treatment of Factor X Deficient Subjects Undergoing Surgery

• IRAS ID

  41663

• Contact name

  Michael Makris

• Sponsor organisation

  Bio Products Laboratory

• Eudract number

  2009-015086-31

• ISRCTN Number

  N/A

• Research summary

  Factor X is being developed as a treatment for participants with a deficiency in clotting Factor X. The purpose of this study is to look at how well Factor X works at preventing excessive blood loss during and after surgery. Finally the study will look at how safe Factor X is by closely following the paticipants progress during the study.

• REC name

  Yorkshire & The Humber - Leeds East Research Ethics Committee

• REC reference

  10/H1306/5

• Date of REC Opinion

  16 Mar 2010

• REC opinion

  Further Information Favourable Opinion